Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights from Genetic and Experimental Models

Yaozhong Liu,Huilun Wang,Minzhi Yu,Lei Cai,Ying Zhao,Yalun Cheng,Yongjie Deng,Yang Zhao,Haocheng Lu,Xiaokang Wu,Guizhen Zhao,Chao Xue,Hongyu Liu,Ida Surakka,Anna Schwendeman,Hong S. Lu,Alan Daugherty,Lin Chang,Jifeng Zhang,Ryan E. Temel,Y. Eugene Chen,Yanhong Guo
DOI: https://doi.org/10.1101/2024.08.07.24311621
2024-08-12
Abstract:Abdominal aortic aneurysm (AAA) is a life-threatening vascular disease without effective medications. This study integrated genetic, proteomic, and metabolomic data to identify causation between increased triglyceride (TG)-rich lipoproteins and AAA risk. Three hypertriglyceridemia mouse models were employed to test the hypothesis that increased plasma TG concentrations accelerate AAA development and rupture. In the angiotensin II-infusion AAA model, most Lpl-deficient mice with severely high plasma TG concentrations died of aortic rupture. Consistently, Apoa5-deficient mice with moderately increased TG concentrations had accelerated AAA development, while human APOC3 transgenic mice with dramatically increased TG concentrations exhibited aortic dissection and rupture. Increased TG concentrations and palmitate inhibited lysyl oxidase maturation. Administration of antisense oligonucleotide targeting Angptl3 profoundly inhibited AAA progression in human APOC3 transgenic mice and Apoe-deficient mice. These results indicate that hypertriglyceridemia is a key contributor to AAA pathogenesis, highlighting the importance of triglyceride-rich lipoprotein management in treating AAA.
Cardiovascular Medicine
What problem does this paper attempt to address?